Gambaran Kejadian Ikutan Pasca Imunisasi Covid-19 pada Mahasiswa Fakultas Kedokteran UKI Penyintas Covid-19 dan Non Penyintas Covid-19

  • Desy Ria Simanjuntak Universitas Kristen Indonesia
  • Jendri Mamangkey Universitas Kristen Indonesia
  • Nive Winda Sari Lumban Tungkup Universitas Kristen Indonesia
  • Anggi Izdihar Mahaswari Universitas Kristen Indonesia
  • Talitha Amalia Universitas Kristen Indonesia
  • Bethaniel Roy Matthew Universitas Kristen Indonesia
Keywords: COVID-19, COVID-19 Vaccine, Adverse Events Following Immunization (AEFI)

Abstract

Adverse Events Following Immunization (AEFI) is defined as 'any adverse medical event that occurs after immunization, but which does not necessarily have a cause-and-effect relationship with vaccine use. Research conducted by krammer, et al  said that vaccine recipients with pre-existing immunity (seropositive) experienced systemic side effects with a much higher frequency than antibody-nave vaccines. UKI Medical Faculty student environment class 2018 and 2019. The research design used is descriptive research with a sample of primary data taken using google form as a media for filling out questionnaires with a sampling method with simple random sampling , then the data is collected and will be processed with the Microsoft program excel. The number of respondents in this study amounted to 229 respondents, consisting of 115 students of class 2018 and 114 students of class 2019. The percentage of students who were non-survivors of COVID-19 was 77.73% and survivors of COVID-19 was 27.73%. Types of vaccines 1,2, and 3 received by the two groups included Sinovac, Astrazeneca, Moderna, and Pfizer. Symptoms of AEFI in non-survivors of COVID-19 are dominated by local symptoms in the form of pain at the injection site (vaccine 1; 88.3%, vaccine 2: 92.6%, vaccine 3: 93.8%), followed by other systemic symptoms such as myalgia., fever, and headache (vaccine 1: 11.7%, vaccine 2: 7.4%, vaccine 3: 6.2%). Symptoms of AEFI in COVID-19 survivors are dominated by local symptoms in the form of pain at the injection site (vaccine 1; 69.05%, vaccine 2: 93.55%, in vaccines 3 respondents experienced mixed local and systemic symptoms. Adverse Event Following Immunization (AEFI) which dominated in both groups in the form of local symptoms such as pain at the injection site, followed by systemic symptoms such as fever, myalgia, and headache

Keywords: COVID-19, COVID-19 Vaccine, Adverse Events Following Immunization (AEFI)

References

Pedoman Pencegahan Dan Pengendalian Coronavirus Disease (COVID-19) Revisi Ke-5. 5th ed. Kementerian Kesehatan RI; 2020. Available from:https://COVID19.go.id/storage/app/media/Protokol/2020/Juli/REV-05_Pedoman_P2_COVID-19_13_Juli_2020.pdf

Direktorat Promosi Kesehatan Kementerian Kesehatan RI. 2022. Poster Menunggu 15 Menit Setelah Divaksinasi COVID-19. Available at: <https://promkes.kemkes.go.id/poster-menunggu-15-menit-setelah-divaksinasi-COVID-19>.

Krammer F, Srivastava K, Simon V. Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine. 2021

Tiissot N, Brunel A, Bozon F, Rosolen B, Chirouze C, Bouiller K. Patients with history of COVID-19 had more side effects after the first dose of COVID-19 vaccine. Vaccine. 2021;39(36):5087-5090.

Pedoman Pencegahan Dan Pengendalian Coronavirus Disease (COVID-19) Revisi Ke-5. 5th ed. Kementerian Kesehatan RI; 2020. Available from:https://COVID19.go.id/storage/app/media/Protokol/2020/Juli/REV-05_Pedoman_P2_COVID-19_13_Juli_2020.pdf

Menteri Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor Hk.01.07/Menkes/413/2020 Tentang Pedoman Pencegahan Dan Pengendalian Coronavirus Disease 2019 (COVID-19). Menteri Kesehatan Republik Indonesia; 2020.

Lambert, N. J. & Survivor Corps COVID-19 “Long Hauler” Symptoms Survey Report Indiana University School of Medicine [2020].

Prioleau T. Learning from the Experiences of COVID-19 Survivors: A Descriptive Study. Learning from the Experiences of COVID-19 Survivors: A Descriptive Study. 2021:1-12.

Apriani V, Utami Dewi W, Nurkinan N. KONSTRUKSI REALITAS SOSIAL DAN MAKNA DIRI PENYINTAS COVID-19 DI JAKARTA. WACANA: Jurnal Ilmiah Ilmu Komunikasi. 2021;20(1).

Baker H, Safavynia S, Evered L. The ‘third wave’: impending cognitive and functional decline in COVID-19 survivors. British Journal of Anaesthesia. 2021;126(1):44-47.

Kemal R, Sari D, Paulina A. Antibody Response to CoronaVac Vaccine in Indonesian COVID-19 Survivor. 2021;.

Heriyanto R, Kurniawan A, Wijovi F, Halim D, Jodhinata C, Marcella E et al. The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia. International Journal of Infectious Diseases. 2021;113:336-338.

Chvatal-Medina M, Mendez-Cortina Y, Patiño P, Velilla P, Rugeles M. Antibody Responses in COVID-19: A Review. Frontiers in Immunology. 2021;12.

Antibodies and the immune system. Centers for Disease Control and Prevention. 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/about-COVID-19/antibodies.html

People testing negative for COVID-19 despite exposure may have ‘immune memory’. The Guardian. 2022. Available from: https://www.theguardian.com/world/2021/nov/10/people-exposed-to-COVID-yet-not-falling-ill-may-have-immune-memory-finds-study

Adverse events following immunization. Who.int. 2022. Available from: https://www.who.int/vaccine_safety/initiative/tech_support/Part-3.pdf?ua=1

Prüβ B. Current State of the First COVID-19 Vaccines. Vaccines. 2021 [cited 15 February 2022];9(1):30. Available from: https://www.mdpi.com/2076-393X/9/1/30

Law B, Sturkenboom M. Adverse Event of Special Interest (AESI): COVID-19. Safety Platform for Emergency vACcines; 2020. Available from: https://www.who.int/docs/default-source/searo/indonesia/COVID19/kipi-aesi-indonesian.pdf?sfvrsn=25b8938b_2

Koesnoe S. Teknis Pelaksanaan Vaksin COVID dan Antisipasi KIPI. Lecture presented at; 2021.

Malik R, Indah D, Wati D, Dewi S, Budiarso L. Upaya Pelaksanaan Dan Pemantauan Kejadian Kipi Pada Pelaksanaan Vaksinasi COVID-19. 2022.

Unicef.org. 2022. Vaksin COVID-19 & KIPI. Available at: <https://www.unicef.org/indonesia/id/media/9896/file/Booklet_Vaksin_COVID-19_%26_KIPI.pdf>.

Satari H. Penanganan, Rujukan Dan Pembiayaan KIPI Vaksinasi COVID-19. Lecture presented at; 2021.

Direktorat Promosi Kesehatan Kementerian Kesehatan RI. 2022. Poster Menunggu 15 Menit Setelah Divaksinasi COVID-19. Available at: <https://promkes.kemkes.go.id/poster-menunggu-15-menit-setelah-divaksinasi-COVID-19.

Riad, Abanoub & Sagiroglu, Derya & Üstün, Batuhan & Pokorná, Andrea & Klugarová, Jitka & Attia, Sameh & Klugar, Miloslav. (2021). Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey. Journal of Clinical Medicine. 10. 10.3390/jcm10122629.

Vicky Jespers (KCE), Roos Leroy (KCE), Frank Hulstaert (KCE), Chloé Wyndham Thomas (Sciensano).Rapid review of the evidence on a COVID-19 booster dose after a primary vaccination schedule. 2021. Available at https://kce.fgov.be/sites/default/files/atoms/files/Third%20COVID-19%20vaccination_Report_DUTCH.pdf

Published
2022-03-31
How to Cite
Ria Simanjuntak, D., Mamangkey, J., Winda Sari Lumban Tungkup, N., Izdihar Mahaswari, A., Amalia, T., & Roy Matthew, B. (2022). Gambaran Kejadian Ikutan Pasca Imunisasi Covid-19 pada Mahasiswa Fakultas Kedokteran UKI Penyintas Covid-19 dan Non Penyintas Covid-19 . Jurnal Pro-Life, 9(1), 347-364. https://doi.org/10.33541/jpvol6Iss2pp102
Section
Articles